Cargando…

Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis

Background: To compare the efficacy and safety of advanced intravitreal therapeutic regimens, including a dexamethasone implant at 350 and 700 μg; a fluocinolone acetonide (FA) implant, 0.2 µg/day, 0.59 and 2.1 mg; intravitreal bevacizumab, 1.25 mg; intravitreal ranibizumab, 0.5 mg; intravitreal tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Weiting, Zhong, Zhenyu, Su, Guannan, Feng, Xiaojie, Yang, Peizeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017745/ https://www.ncbi.nlm.nih.gov/pubmed/35450045 http://dx.doi.org/10.3389/fphar.2022.749312

Ejemplares similares

The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
por: Xiong, Anji, et al.
Publicado: (2021)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter, Rebecca S, et al.
Publicado: (2011)

Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Biao, et al.
Publicado: (2021)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010)

Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan, Hui Yi, et al.
Publicado: (2016)

Intravitreal therapeutic agents in noninfectious uveitic macular edema
por: Shah, Kunal Kaushik, et al.
Publicado: (2018)

Case Report: A Promising Treatment Strategy for Noninfectious Uveitis
por: Liu, Xiao-Bao, et al.
Publicado: (2022)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Risk for uveitis relapse after COVID-19 vaccination
por: Zhong, Zhenyu, et al.
Publicado: (2022)

Biologics for the treatment of noninfectious uveitis
por: Lin, Chang-Ping
Publicado: (2018)

Intraocular therapy in noninfectious uveitis
por: Modugno, Rocco Luigi, et al.
Publicado: (2021)

Update on the use of systemic biologic agents in the treatment of noninfectious uveitis
por: Pasadhika, Sirichai, et al.
Publicado: (2014)

Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis
por: Palla, Swetha, et al.
Publicado: (2015)

Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
por: Sheppard, John D, et al.
Publicado: (2012)

Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place of Intravitreal Anti-VEGF Therapy
por: Karti, Omer, et al.
Publicado: (2020)

Efficacy and Safety of Immunosuppressant Therapy for Noninfectious Uveitis: A Systematic Review and Meta-Analysis
por: Zuo, Haihong, et al.
Publicado: (2021)

Safety and Efficacy of Suprachoroidal Injection of Triamcinolone in Treating Macular Edema Secondary to Noninfectious Uveitis
por: Hanif, Junaid, et al.
Publicado: (2021)

Voclosporin as a Treatment for Noninfectious Uveitis
por: Schultz, Clyde
Publicado: (2013)

Targeting interleukin-6 for noninfectious uveitis
por: Lin, Phoebe
Publicado: (2015)

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail, Adnan, et al.
Publicado: (2018)

Early vs Deferred Non–Messenger RNA COVID-19 Vaccination Among Chinese Patients With a History of Inactive Uveitis: A Randomized Clinical Trial
por: Zhong, Zhenyu, et al.
Publicado: (2023)

Clinical Outcomes of Cyclosporine Treatment for Noninfectious Uveitis
por: Lee, Sun Ho, et al.
Publicado: (2012)

New pharmacotherapy options for noninfectious posterior uveitis
por: Pleyer, Uwe, et al.
Publicado: (2021)

Noninfectious Uveitis in Rheumatology: Patterns, Treatment, and Outcomes
por: Younus, Raheel, et al.
Publicado: (2023)

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder, Steven J, et al.
Publicado: (2015)

HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis
por: Zhong, Zhenyu, et al.
Publicado: (2021)

Noninfectious uveitis: strategies to optimize treatment compliance and adherence
por: Dolz-Marco, Rosa, et al.
Publicado: (2015)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
por: Roesel, Martin, et al.
Publicado: (2011)

Emerging Therapies for Noninfectious Uveitis: What May Be Coming to the Clinics
por: Maya, Jose R., et al.
Publicado: (2014)

A review and update on orphan drugs for the treatment of noninfectious uveitis
por: You, Caiyun, et al.
Publicado: (2017)

Biological Therapy in Noninfectious Pediatric Uveitis: A Systematic Review
por: Norcia, Luiz Fernando, et al.
Publicado: (2021)

Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma
por: Yousef, Yacoub A., et al.
Publicado: (2021)

AAPOS Pediatric Uveitis Committee: COVID-19—infection, inflammation, and challenges in children with noninfectious uveitis
por: Bohnsack, Brenda, et al.
Publicado: (2022)

The Efficacy and Safety of Adalimumab in Treating Pediatric Noninfectious Chronic Anterior Uveitis With Peripheral Retinal Vascular Leakage: A Pilot Study
por: Song, Hang, et al.
Publicado: (2022)

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
por: Al-Dhibi, Hassan, et al.
Publicado: (2014)

Levels of thrombopoietin in aqueous humor of patients with noninfectious acute anterior uveitis
por: Mondejar, José-Juan, et al.
Publicado: (2015)

Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis
por: Tagirasa, Ravichandra, et al.
Publicado: (2020)

Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis
por: Saade, Joanna S., et al.
Publicado: (2021)

Comprehensive LncRNA and Potential Molecular Mechanism Analysis in Noninfectious Uveitis
por: Lu, Shiheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qkvu6l51r5nn6tslnp655hifgk